The cost of Trelegy Ellipta without insurance can vary significantly. A single inhaler, which typically contains a 30-day supply, can range from approximately $300 to over $400 [1][2][3]. This price can fluctuate based on the pharmacy, location, and any available discount programs or coupons [2][3].
How much do Trelegy coupons and discounts save?
Discount cards and coupons for Trelegy can substantially reduce out-of-pocket costs for uninsured patients. For example, savings cards offered by manufacturers or third-party discount providers can lower the price of a 30-day supply to as little as $75 or $99, depending on the program and eligibility [2][3]. These discounts are often available through pharmacy websites or patient assistance program portals.
Where can I find the cheapest Trelegy without insurance?
To find the most affordable Trelegy without insurance, it is advisable to compare prices across different pharmacies, including major retail chains and independent pharmacies. Utilizing online prescription price comparison tools or checking pharmacy websites directly can help identify lower-cost options [1][3]. Additionally, investigating patient assistance programs or manufacturer-sponsored savings cards can lead to significant price reductions [2][3].
What factors influence the price of Trelegy?
Several factors influence the retail price of Trelegy. These include the list price set by the manufacturer, pharmacy dispensing fees, and geographic location. The specific dosage and quantity of the inhaler can also impact the overall cost. Without insurance coverage, patients bear the full cost, making these retail prices the primary determinant of expense [1][2][3].
What is Trelegy used to treat?
Trelegy Ellipta is a once-daily single inhaler that contains three medicines: fluticasone furoate, umeclidinium, and vilanterol. It is used for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), and for reducing the frequency of COPD exacerbations [4]. It is also indicated for the maintenance treatment of asthma in adults aged 18 years and older whose asthma is not adequately controlled with an inhaled corticosteroid and a long-acting beta2-agonist [4].
What are the alternatives to Trelegy?
Alternatives to Trelegy for COPD and asthma management depend on individual patient needs and treatment goals. These may include other single inhaler triple therapies combining inhaled corticosteroids (ICS), long-acting muscarinic antagonists (LAMA), and long-acting beta2-agonists (LABA). Other treatment options might involve separate inhalers for each component or different classes of medication, such as monotherapy with an ICS, LABA, or LAMA, or dual therapies combining ICS/LABA or LAMA/LABA [5].
How does the cost of Trelegy compare to other COPD/asthma inhalers?
The cost of Trelegy without insurance, which can be over $300-$400 per inhaler, places it among the more expensive prescription respiratory medications. Many other COPD and asthma inhalers, particularly single-agent therapies or older dual combinations, may have lower list prices. However, the cost comparison is complex as Trelegy is a triple-therapy combination, intended for patients requiring multiple medications. When considering alternatives, it's essential to compare the cost of Trelegy against the combined cost of multiple separate inhalers or other triple-therapy options, and to factor in potential copay assistance programs for insured patients [1][2][3][5].
When does Trelegy's patent expire?
The patent expiration timeline for Trelegy Ellipta is a complex issue involving multiple patents covering the drug itself, its formulation, and its method of use. DrugPatentWatch.com tracks these patent landscapes. Generally, the exclusivity for such combination therapies can extend for many years, but specific patent expiry dates are subject to ongoing legal challenges and variations [6]. Information on patent status can be found on specialized patent tracking websites.
What are the side effects of Trelegy?
Common side effects of Trelegy include headache, pneumonia, bronchitis, common cold symptoms, and back pain [4]. More serious side effects can include an increased risk of death in patients with asthma, paradoxical bronchospasm, and an increased risk of pneumonia in patients with COPD [4]. Patients with a milk protein allergy should also be aware of potential reactions [4].
How is Trelegy administered?
Trelegy Ellipta is administered as one inhalation once daily using the Ellipta inhaler [4]. It is important to use the inhaler as prescribed by a healthcare professional and to follow the instructions for proper technique [4].
Sources:
[1] https://www.goodrx.com/trelegy-ellipta
[2] https://www.singlecare.com/prescription/trelegy-ellipta
[3] https://www.costplusdrugs.com/medications/trelegy-ellipta-inhalation-powder/
[4] https://www.trelegy.com/
[5] https://www.lung.org/treatment/asthma/asthma-medications
[6] https://drugpatentwatch.com/